Previous studies using the K7M2 lung metastatic osteosarcoma model have shown that immune checkpoint inhibitors anti-PD-L1 and anti-CTLA-4 are efficacious when treatment is initiated very early after tumor seeding [11,12]. This evidence concerns the gene CD274 and neoplasm.